JeffreyJohnTosoianMD

PubMed

• Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer.
  Jeffrey J Tosoian, Yuping Zhang, Lanbo Xiao, Cassie Xie, Nathan L Samora, Yashar S Niknafs, Zoey Chopra, Javed Siddiqui, Heng Zheng, Grace Herron, Neil Vaishampayan, H...> ;JAMA Oncology. 2024 Apr 18
• A Pragmatic Approach to Prostate Cancer Screening.
  Arul M Chinnaiyan, Jeffrey J Tosoian, David F Penson> ;JAMA. 2024 Apr 6
• Editorial Comment.
  Robinson, H., Cole, M., Tosoian, J.> ;The Journal of Urology. 2024 Mar 1
• Point of View: Innovation and Progress for Screening and Management of Localized Prostate Cancer: What an Exciting Time.
  Jeffrey J Tosoian, Alice Yu, Wayne G Brisbane> ;The Journal of Urology. 2024 Feb 1
• Clinical consequences of a genetic predisposition toward higher benign prostate-specific antigen levels.
  Mingjian Shi, John P Shelley, Kerry R Schaffer, Jeffrey J Tosoian, Minoo Bagheri, John S Witte, Linda Kachuri, Jonathan D Mosley> ;Ebiomedicine. 2023 Nov 1
• 5 citations
  Optimizing detection of clinically significant prostate cancer through nomograms incorporating mri, clinical features, and advanced serum biomarkers in biopsy naïve men.
  Siddiqui, M., Li, E., Kumar, S., Busza, A., Lin, J., Mahenthiran, A., Aguiar, J., Shah, P., Ansbro, B., Rich, J., Moataz, S., Keeter, M., Mai, Q., Mi, X., Tosoian, J.,...> ;Prostate Cancer and Prostatic Diseases. 2023 Sep 1
• Accurate Documentation Contributes to Guideline-concordant Surveillance of Nonmuscle Invasive Bladder Cancer: A Multisite Department of Veterans Affairs Study.
  Vikram Lyall, A Aziz Ould Ismail, David A Haggstrom, Muta M Issa, M Minhaj Siddiqui, Jeffrey Tosoian, Florian R Schroeck> ;Urology. 2023 Nov 1
• Point-Counterpoint: Clinical Pragmatism Should Prevail Over Biological Orthodoxy: "Pro" Perspective.
  David F Penson, Jeffrey J Tosoian> ;The Journal of Urology. 2023 Jul 1
• Editorial Comment.
  Hunter S Robinson, Nathan L Samora, Jeffrey J Tosoian> ;The Journal of Urology. 2023 Jul 1
• 6 citations
  Use of Active Surveillance vs Definitive Treatment Among Men With Low- and Favorable Intermediate-Risk Prostate Cancer in the US Between 2010 and 2018.
  Bashir Al Hussein Al Awamlh, Daniel A Barocas, Alec Zhu, Jeffrey J Tosoian, Lee Ponsky, Serban Negoita, Jonathan E Shoag> ;JAMA Internal Medicine. 2023 Jun 1
• 3 citations
  A Polygenic Risk Score for Prostate Cancer Risk Prediction.
  Kerry R Schaffer, Mingjian Shi, John P Shelley, Jeffrey J Tosoian, Linda Kachuri, John S Witte, Jonathan D Mosley> ;JAMA Internal Medicine. 2023 Apr 1
• National Trends in the Practice of Active Surveillance.
  Olutiwa A Akinsola, Taryn A Ellis, Jeffrey J Tosoian> ;The Journal of Urology. 2023 Apr 1
• 1 citations
  Combined Use of Magnetic Resonance Imaging and Biomarker Testing to Detect Clinically Significant Prostate Cancer.
  Nathan L Samora, Bashir Al Hussein Al Awamlh, Jeffrey J Tosoian> ;The Urologic Clinics of North America. 2023 Feb 1
• Editorial Commentary.
  Nathan L Samora, Jeffrey J Tosoian> ;Urology Practice. 2023 Jan 1
• 1 citations
  MyProstateScore in men considering repeat biopsy: validation of a simple testing approach.
  Jeffrey J Tosoian, Michael S Sessine, Bruce J Trock, Ashley E Ross, Cassie Xie, Yingye Zheng, Nathan L Samora, Javed Siddiqui, Yashar Niknafs, Zoey Chopra, Scott Tomli...> ;Prostate Cancer and Prostatic Diseases. 2023 Sep 1
• 3 citations
  Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy.
  Stefan E Eng, Benjamin Basasie, Alfonso Lam, O John Semmes, Dean A Troyer, Geoffrey D Clarke, Abhijit G Sunnapwar, Robin J Leach, Teresa L Johnson-Pais, Lori J Sokoll,...> ;Prostate Cancer and Prostatic Diseases. 2024 Mar 1
• The evolving clinical use of prostate cancer biomarkers.
  Nathan L Samora, Jacob E Tallman, Jeffrey J Tosoian> ;Prostate Cancer and Prostatic Diseases. 2022 Sep 1
• Editorial Comment.
  Olutiwa A Akinsola, Bryn M Launer, Jeffrey J Tosoian> ;The Journal of Urology. 2022 Nov 1
• 19 citations
  Active Surveillance for Intermediate-risk Prostate Cancer: A Systematic Review, Meta-analysis, and Metaregression.
  Michael Baboudjian, Alberto Breda, Pawel Rajwa, Andrea Gallioli, Bastien Gondran-Tellier, Francesco Sanguedolce, Paolo Verri, Pietro Diana, Angelo Territo, Cyrille Bas...> ;European Urology Oncology. 2022 Dec 1
• Editorial Comment.
  Michael S Sessine, Nathan L Samora, Jeffrey J Tosoian> ;The Journal of Urology. 2022 Sep 1
• 7 citations
  Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need.
  Eyrich, N., Jeffrey J Tosoian, Udit Singhal, Matthew S Davenport, John T Wei, Jeffrey S Montgomery, Arvin K George, Simpa S Salami, Stanley G Mukundi, Javed Siddiqui, ...> ;Urology. 2022 Jun 1
• 4 citations
  Prostate Cancer With Peritoneal Carcinomatosis: A Robotic-assisted Radical Prostatectomy-based Case Series.
  Melissa A Reimers, Udit Singhal, Mark Farha, Rohit Mehra, Morand Piert, Jeffrey J Tosoian, Parth K Modi, Nicole Curci, James Peabody, Eduardo Kleer, David C Smith, Tod...> ;Urology. 2022 Sep 1
• Editorial Comment.
  Benjamin V Stone, Mary E Hall, Jeffrey J Tosoian> ;The Journal of Urology. 2022 Apr 1
• 15 citations
  Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Pros...
  Amar U Kishan, Alison Steigler, James W Denham, Almudena Zapatero, Araceli Guerrero, David Joseph, Xavier Maldonado, Jessica K Wong, Bradley J Stish, Robert T Dess, Av...> ;JAMA Oncology. 2022 Mar 1
• 1 citations
  Awaiting the perfect diagnostic test: optimal prostate cancer care begins without a diagnosis.
  Jeffrey J Tosoian> ;Prostate Cancer and Prostatic Diseases. 2022 Feb 1
• Join now to see all

Journal Articles

• Evaluation of Patient- and Surgeon-Specific Variations in Patient-Reported Urinary Outcomes 3 Months After Radical Prostatectomy from a Statewide Improvement Collabora...  
  Gregory B Auffenberg, Jeffrey Tosoian, Richard Sarle, William K Johnston, Eduardo Kleer, Khurshid R Ghani, James Montie, JAMA Surgery
• Association of Tumor-Infiltrating T-cell Density with Molecular Subtype, Racial Ancestry and Clinical Outcomes in Prostate Cancer  
  Tamara L Lotan, Edward M Schaeffer, Jeffrey J Tosoian, Scott A Tomlins, Nature